60
Views
3
CrossRef citations to date
0
Altmetric
Review

Lessons learned from peginesatide in the treatment of anemia associated with chronic kidney disease in patients on dialysis

&
Pages 243-246 | Published online: 11 Nov 2013

References

  • WatsonAJAdverse effects of therapy for the correction of anemia in hemodialysis patientsSemin Nephrol19899Suppl 130342648519
  • KissZElliottSJedynastyKTesarVSzegediJDiscovery and basic pharmacology of erythropoiesis-stimulating agents (ESAs), including the hyperglycosylated ESA, darbepoetin alfa: an update of the rationale and clinical impactEur J Clin Pharmacol20106633134020127232
  • MacdougallICCERA (continuous erythropoietin-receptor activator): a new erythropoiesis-stimulating agent for the treatment of anemiaCurr Hematol Rep2005443644016232379
  • SchmidHPeginesatide for the treatment of renal disease-induced anemiaExp Opin Pharmacother201314937948
  • GreenJMPeginesatide and erythropoietin stimulate similar erythropoietin receptor-mediated signal transduction and gene induction eventsExp Hematol20124057558722406924
  • FanQLeutherKKHolmesCPPreclinical evaluation of hematide, a novel erythropoiesis stimulating agent, for the treatment of anemiaExp Hematol2006341303131116982323
  • WoodburnKWPeginesatide clearance, distribution, metabolism, and excretion in monkeys following intravenous administrationDrug Metab Dispos20134177478423318685
  • SteadRBEvaluation of the safety and pharmacodynamics of hematide, a novel erythropoietic agent, in a phase 1, double-blind, placebo-controlled, dose-escalation study in healthy volunteersBlood20061081830183416720830
  • MacdougallICProvenzanoRSharmaAPEARL Study GroupsPeginesatide for anemia in patients with chronic kidney disease not receiving dialysisN Engl J Med201336832033223343062
  • FishbaneSSchillerBLocatelliFEMERALD Study GroupsPeginesatide in patients with anemia undergoing hemodialysisN Engl J Med201336830731923343061
  • AgarwalAKDrug safety profile of darbepoetin alfa for anemia of chronic kidney diseaseExpert Opin Drug Saf2009814515319309243
  • MacdougallICRossertJCasadevallNA peptide-based erythropoietin-receptor agonist for pure red-cell aplasiaN Engl J Med20093611848185519890127
  • LocatelliFDel VecchioLPeginesatide as a new approach for treating anemia of CKD patient: is it like a falling star?Expert Opin Pharmacother2013141277127823675762